GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nihon Kohden Corp (TSE:6849) » Definitions » Debt-to-EBITDA

Nihon Kohden (TSE:6849) Debt-to-EBITDA : 0.07 (As of Dec. 2023)


View and export this data going back to 1961. Start your Free Trial

What is Nihon Kohden Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Nihon Kohden's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円442 Mil. Nihon Kohden's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円0 Mil. Nihon Kohden's annualized EBITDA for the quarter that ended in Dec. 2023 was 円6,704 Mil. Nihon Kohden's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.07.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Nihon Kohden's Debt-to-EBITDA or its related term are showing as below:

TSE:6849' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.01   Med: 0.03   Max: 0.06
Current: 0.02

During the past 13 years, the highest Debt-to-EBITDA Ratio of Nihon Kohden was 0.06. The lowest was 0.01. And the median was 0.03.

TSE:6849's Debt-to-EBITDA is ranked better than
97.67% of 429 companies
in the Medical Devices & Instruments industry
Industry Median: 1.21 vs TSE:6849: 0.02

Nihon Kohden Debt-to-EBITDA Historical Data

The historical data trend for Nihon Kohden's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nihon Kohden Debt-to-EBITDA Chart

Nihon Kohden Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.02 0.01 0.01 0.02

Nihon Kohden Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.01 0.01 0.01 0.07

Competitive Comparison of Nihon Kohden's Debt-to-EBITDA

For the Medical Devices subindustry, Nihon Kohden's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nihon Kohden's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nihon Kohden's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Nihon Kohden's Debt-to-EBITDA falls into.



Nihon Kohden Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Nihon Kohden's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(424 + 17) / 28517
=0.02

Nihon Kohden's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(442 + 0) / 6704
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Nihon Kohden  (TSE:6849) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Nihon Kohden Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Nihon Kohden's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Nihon Kohden (TSE:6849) Business Description

Traded in Other Exchanges
Address
31-4 Nishiochiai 1-chome, Shinjuku-ku, Tokyo, JPN, 1618560
Nihon Kohden Corp manufactures electronic medical equipment. The firm operates in four categories: physiological measuring equipment, treatment equipment, patient monitors, and other medical equipment. The patient monitors segment contributes the largest proportion of revenue and includes continuous monitoring instruments and clinical information systems. The physiological measuring equipment segment sells electroencephalographs, electrocardiographs, and diagnostic information systems. The treatment equipment segment sells defibrillators, pacemakers, ventilators, and related consumables. The other medical equipment segment sells automated hematology analyzers, ultrasound diagnostic equipment, and other laboratory equipment. Nihon Kohden generates the majority of its revenue in Japan.

Nihon Kohden (TSE:6849) Headlines

No Headlines